Astaxanthin inhibits oxidative stress and apoptosis in diabetic retinopathy

Jian Fang1, Wuxia Bai2, Lina Yang1

  • 1Department of Ophthalmology, Xinchang County People's Hospital, Shaoxing City, Zhejiang Province 312500, China.

Acta Histochemica
|June 21, 2023
PubMed
Abstract

Insights

Astaxanthin (ASX) protects against diabetic retinopathy (DR) by reducing oxidative stress and inflammation. It activates the Nrf2/Keap1 pathway, alleviating retinal damage and apoptosis in DR rat models.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Biochemistry

Background:

  • Diabetic retinopathy (DR) pathophysiology is linked to oxidative stress.
  • Astaxanthin (ASX), a natural antioxidant, has potential therapeutic benefits for DR.
  • The precise mechanism of ASX in preventing DR development requires elucidation.

Purpose of the Study:

  • To investigate the antioxidant mechanism of Astaxanthin (ASX) in a rat model of diabetic retinopathy (DR).
  • To evaluate the effects of ASX on oxidative stress, inflammation, and apoptosis in DR.
  • To determine the role of the Nrf2/Keap1 pathway in ASX-mediated protection against DR.

Main Methods:

  • Diabetic retinopathy (DR) was induced in rats using streptozotocin.
  • Rats were treated with Astaxanthin (ASX) for 45 days.
  • Retinal tissues were analyzed for inflammation, oxidative stress, antioxidant enzymes, and apoptosis markers using techniques including ELISA, immunohistochemistry, and western blot, with a focus on the Nrf2/Keap1 pathway.

Main Results:

  • Astaxanthin (ASX) treatment alleviated retinal tissue damage, increasing retina thickness and ganglion cell layer (GCL) cell numbers.
  • ASX demonstrated anti-inflammatory, anti-oxidative stress, and anti-apoptotic effects in DR rat models.
  • ASX inhibited Keap1 expression, promoted Nrf2 nuclear translocation, and upregulated antioxidant enzymes like HO-1, NQO1, γ-GCS, and GPx.

Conclusions:

  • Astaxanthin (ASX) exerts antioxidant effects via the Nrf2/Keap1 pathway.
  • This mechanism alleviates apoptosis, inflammation, and oxidative stress in the retinal tissues of diabetic retinopathy (DR) rats.
  • ASX shows promise as a therapeutic agent for managing diabetic retinopathy (DR).

Related Concept Videos